Lack of association of miR-146a rs2910164 polymorphism with Gastrointestinal cancers: Evidence from 10206 subjects

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Wang, Fang ^a   Sun, Guoping ^a   Zou, Yanfeng ^a   Fan, Lulu ^a   Song, Bing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GUANINE; MICRORNA 146A;

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; META ANALYSIS (TOPIC); POPULATION GENETICS; QUALITY CONTROL; RISK ASSESSMENT; RNA ANALYSIS; SYSTEMATIC REVIEW;

GASTROINTESTINAL NEOPLASMS; HUMANS; MICRORNAS; POLYMORPHISM, GENETIC;

EID: 84862993291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039623     Document Type: Article

References (46)

1. Babashah S, Soleimani M, (2011) The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47: 1127-1137.
2. Cai Y, Yu X, Hu S, Yu J, (2009) A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics 7: 147-154.
3. Hui A, How C, Ito E, Liu FF, (2011) Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer 11: 500.
4. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M, (2011) Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 45: 355-360.
5. Yoon SO, Chun SM, Han EH, Choi J, Jang SJ, et al. (2011) Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. Hum Pathol 42: 1391-1400.
6. Ji J, Shi J, Budhu A, Yu Z, Forgues M, et al. (2009) MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447.
7. Kan T, Sato F, Ito T, Matsumura N, David S, et al. (2009) The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136: 1689-1700.
8. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, et al. (2010) miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814.
9. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
10. Landi D, Moreno V, Guino E, Vodicka P, Pardini B, et al. (2011) Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutat Res 17: 109-115.
11. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557.
12. de la Chapelle A, Jazdzewski K, (2011) MicroRNAs in thyroid cancer. J Clin Endocrinol Metab 96: 3326-3336.
13. Hou Z, Xie L, Yu L, Qian X, Liu B, (2011) MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis. Med Oncoldoi: 10.1007/s12032-011-9862-7.
14. Yu J, Li A, Hong SM, Hruban RH, Goggins M, (2012) MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 18: 981-992.
15. Labbaye C, Testa U, (2012) The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol 5: 13.
16. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608.
17. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105: 7269-7274.
18. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, et al. (2010) Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 55: 2288-2293.
19. Chen S, He Y, Ding J, Jiang Y, Jia S, et al. (2010) An insertion/deletion polymorphism in the 3′ untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun 391: 552-556.
20. Oshima H, Oshima M, (2012) The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol 47: 97-106.
21. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, et al. (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609-614.
22. Xiang Y, Fan S, Cao J, Huang S, Zhang LP, (2012) Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Repdoi:10.1007/s11033-012-1532-0.
23. Min KT, Kim JW, Jeon YJ, Jang MJ, Chong SY, et al. (2011) Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinogdoi: 10.1002/mc.21849.
24. Zhou J, Lv R, Song X, Li D, Hu X, et al. (2011) Association Between Two Genetic Variants in miRNA and Primary Liver Cancer Risk in the Chinese Population. DNA Cell Biol doi:10.1089/dna.2011.1340.
25. Akki{dotless}z H, Bayram S, Bekar A, Akgöllü E, Usküdar O, et al. (2011) No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene 486: 104-109.
26. Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, et al. (2011) Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 45: 239-243.
27. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, et al. (2010) Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15: 524-531.
28. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, et al. (2011) Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4+3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig Dis Sci 56: 1131-1137.
29. Guo H, Wang K, Xiong G, Hu H, Wang D, et al. (2010) A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han. Fam Cancer 9: 599-603.
30. Zeng Y, Sun QM, Liu NN, Dong GH, Chen J, et al. (2010) Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol 16: 3578-3583.
31. Srivastava K, Srivastava A, Mittal B, (2010) Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 55: 495-499.
32. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, et al. (2008) A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29: 2126-2131.
33. Ye Y, Wang KK, Gu J, Yang H, Lin J, et al. (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1: 460-469.
34. Jiang DK, Wang WZ, Ren WH, Yao L, Peng B, et al. (2011) TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis. J Invest Dermatol 131: 220-228.
35. Zou YF, Wang F, Feng XL, (2011) TP53 Arg72Pro polymorphism may have little involvement in the pathogenesis of skin cancer in Caucasians. J Invest Dermatol 131: 781-782.
36. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
37. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
38. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
39. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
40. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
41. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315: 629-634.
42. Xu W, Xu J, Liu S, Chen B, Wang X, et al. (2011) Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One 6: e20471.
43. Qiu LX, He J, Wang MY, Zhang RX, Shi TY, et al. (2011) The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine 56: 695-698.
44. Wang J, Bi J, Liu X, Li K, Di J, et al. (2011) Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol Biol Repdoi:10.1089/dna.2011.1340.
45. Duan R, Pak C, Jin P, (2007) Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16: 1124-1131.
46. Yu H, Liu H, Wang LE, Wei Q, (2012) A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS One 7: e30566.